|
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,9640 USD | +0,64% |
|
+1,29% | -17,16% |
| 11/06 | Rein Therapeutics étend son essai clinique de phase 2 RENEW au Royaume-Uni | CI |
| 18/05 | Rein Therapeutics annonce la clôture d'une offre publique souscrite de 57,5 millions de dollars | RE |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,64% | +1,29% | -8,49% | -29,35% | -17,16% | -47,20% | -47,61% | -96,28% | - | 89,12 M | |
| -2,86% | -0,26% | +9,81% | +23,41% | +6,19% | +57,57% | +110,98% | +194,35% | +6 583,06% | 56,42 Md | |
| -0,34% | +2,91% | -3,53% | +9,35% | +9,63% | +45,55% | +46,87% | -31,95% | - | 44,54 Md | |
| +0,67% | +6,55% | +1,73% | +0,62% | -4,31% | -14,32% | -19,38% | -58,24% | - | 22,9 Md | |
| +0,16% | +4,27% | -10,03% | -32,09% | -43,58% | -3,34% | +390,73% | +235,02% | +858,00% | 21,21 Md | |
| -0,51% | -5,56% | -5,27% | -10,43% | -1,65% | +10,43% | -29,97% | -75,22% | - | 16,4 Md | |
| -1,54% | -1,06% | -5,71% | -7,03% | -21,36% | +8,10% | -39,28% | -41,09% | +43,86% | 15,4 Md | |
| -0,94% | +1,96% | +5,24% | +28,45% | +20,36% | +26,36% | +176,20% | +133,02% | +614,84% | 13,35 Md | |
| +0,96% | +6,56% | -3,59% | +6,18% | +6,88% | +20,81% | - | - | - | 12,36 Md | |
| +0,32% | +1,60% | +21,74% | +44,90% | +102,55% | +96,37% | +207,56% | +1 038,43% | +400,46% | 11,15 Md | |
| +2,72% | +5,48% | -5,88% | +11,81% | -15,36% | +72,91% | +92,89% | +367,24% | - | 11,08 Md | |
| +2,46% | +2,06% | -14,64% | -10,97% | -17,67% | -27,82% | +620,00% | +119,51% | +76,47% | 10,87 Md | |
| -2,88% | -4,54% | -27,83% | -18,92% | -20,93% | -6,78% | +169,13% | +37,25% | - | 10,82 Md | |
| +2,70% | +3,85% | +0,05% | +33,70% | +15,54% | +388,57% | +114,62% | -11,46% | +1 220,22% | 10,5 Md | |
| +0,14% | +39,47% | +20,65% | +24,01% | +22,70% | +61,71% | +176,23% | - | - | 9,74 Md | |
| +0,64% | +3,97% | -6,93% | +16,05% | +11,10% | +108,98% | +99,20% | +216,85% | +686,14% | 9,52 Md | |
| -3,22% | +2,34% | -19,79% | -18,75% | +0,21% | +34,73% | +108,53% | -42,14% | - | 7,93 Md | |
| +1,06% | +0,63% | -9,47% | -12,12% | +264,39% | +130,51% | +158,60% | -50,03% | - | 7,44 Md | |
| +1,12% | +1,69% | -14,33% | -15,13% | -39,23% | - | - | - | - | 7,33 Md | |
| -0,70% | +0,91% | -0,70% | +8,47% | +5,62% | +17,07% | +73,82% | +0,97% | +249,72% | 7,13 Md | |
| Moyenne | +0,02% | +3,06% | -3,85% | +2,61% | +14,20% | +51,59% | +133,84% | +113,90% | +1 192,53% | 15,31 Md | |
| Moyenne pondérée par Capi. | -0,47% | +3,05% | -1,34% | +6,55% | +8,23% | +48,09% | +124,93% | +114,53% | +2 731,43% |
- Bourse
- Actions
- Action RNTX
- Secteur Rein Therapeutics Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
